Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML).
暂无分享,去创建一个
J. Cortes | R. Stone | J. Lancet | G. Uy | R. Lindsley | S. Faderl | E. Ritchie | T. Prebet | C. Gibson | R. Ryan | H. Murdock | T. Lin